Active	Status	Sponsor type	Region	Phase	Filter
2 Active 7 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
M1069 / EMD Serono, Domain Therap
MS201929_0032, NCT05198349: First in Human Study of M1069 in Advanced Solid Tumors	Terminated	1	15	Canada, US	M1069	EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany	Metastatic or Locally Advanced Unresectable Solid Tumors	05/23	08/23
DT-9081 / Domain Therap
EPRAD, NCT05582850: DT-9081 Study in Participants with Advanced, Recurrent or Metastatic Solid Tumours	Active, not recruiting	1	48	Europe	DT-9081 - dose escalation, Phase 1 dose-escalation part, DT-9081 - expansion, Phase 1 expansion part	Domain Therapeutics SA	Solid Tumor, Adult	07/25	10/25